N
AMGN icon

Natixis’s Amgen AMGN Stock Holding History

Natixis’s Portfolio AMGN Stock Details AMGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-32,500
Closed -$9.24M – 990
2024
Q1 		$9.24M Buy
+32,500
New +$9.51M 0.05% 244
2022
Q3 		– Sell
-738
Closed -$180K – 1076
2022
Q2 		$180K Buy
+738
New +$181K ﹤0.01% 1038

Other funds holding AMGN

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Natixis's AMGN Position: Q1 2026 in Review

Natixis reduced its Amgen (AMGN) stake by 89% in Q1 2026, selling an estimated $50.5M and leaving 17,885 shares worth $6.29M. The position accounts for 0.02% of the portfolio, ranked #391.

Natixis first reported a position in AMGN in Q2 2013 and has held it in 43 quarters since. The position peaked at $230M in Q3 2019. 3,128 funds tracked by Wall St. Rank hold AMGN as of Q1 2026.

  • Natixis held 17,885 shares of Amgen worth $6.29M as of Q1 2026.
  • Natixis sold 141,761 Amgen shares in Q1 2026, an estimated $50.5M.
  • Amgen made up 0.02% of Natixis's portfolio in Q1 2026, its #391 holding.
  • Natixis first reported a position in Amgen in Q2 2013 and has held it in 43 quarters since.
  • Natixis's Amgen position peaked at $230M in Q3 2019.
  • 3,128 funds tracked by Wall St. Rank held Amgen as of Q1 2026.

Based on Natixis's 13F filing for Q1 2026, filed 14 May 2026.